The recent acquisition of Nalu Medical necessitates the integration of its people, processes, and technology into Boston Scientific's ecosystem.
Filing excerpt
During the first quarter of 2026, cash provided by (used for) investing activities included net cash payments of $523 million for the acquisition of Nalu Medical, Inc.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Competitors named
sec-10qsoftwareImplementationGet every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/f8eb7a21-aba9-4228-8f92-c48f72f981ba returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "f8eb7a21-aba9-4228-8f92-c48f72f981ba",
"signal_type": "sec-10q",
"signal_subtype": "softwareImplementation",
"detected_at": "2026-05-05T08:48:22.684+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "The recent acquisition of Nalu Medical necessitates the integration of its people, processes, and technology into Boston Scientific's ecosystem. This creates immediate needs for system consolidation (ERP, CRM, HR) and data migration services to realize acquisition synergies.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Net cash payments for the acquisition of Nalu Medical, Inc.",
"dollar_millions": 523
},
"summary": "Acquired Nalu Medical, Inc. for $523M in Q1 2026, triggering immediate integration activities.",
"excerpts": "During the first quarter of 2026, cash provided by (used for) investing activities included net cash payments of $523 million for the acquisition of Nalu Medical, Inc.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000033/bsx-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Implementation partner opportunity",
"signal_category": "technology",
"competitors_mentioned": [
"Nalu Medical, Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/f8eb7a21-aba9-4228-8f92-c48f72f981ba \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.